Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Pari Pharma GmbH currently has 3 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are being reviewed by 3 distinct examiners, meaning each pending matter is assigned to a different individual. The prosecution is spread across 2 distinct art units, which suggests some technical variety within the company's mechanical and medical device filings.
The busiest examiner for this portfolio is JANG, JAEICK, who handles 1 pending office action. With a total of 3 pending office actions, the workload is evenly distributed, and no single examiner has a dominant role in the current prosecution. This requires the applicant to manage separate examiner relationships while navigating the procedural nuances of 2 distinct art units. The focus on Medical Devices & Mechanical Engineering ensures that the technical scope remains within a defined field.
Managing 3 pending office actions across 3 distinct examiners requires a coordinated effort to maintain consistency. Since JANG, JAEICK and the other examiners are working within only 2 distinct art units, there may be some overlap in the technical standards applied to the cases. Practitioners should look for commonalities in the feedback from the art units to streamline their responses. This structure allows for a relatively focused approach to the company's intellectual property goals in the medical device sector.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| §112 only | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JANG, JAEICK | 1 | 66.7% | +52.6% |
| JONAITIS, JUSTIN M | 1 | 61.0% | +38.7% |
| GREIG, THOMAS W | 1 | 74.7% | +23.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17785493 | CONTROL DEVICE FOR AEROSOL NEBULIZER SYSTEM | GREIG, THOMAS W | 14d |
| 18832326 | INHALATION THERAPY APPARATUS | JANG, JAEICK | — |
| 35519927 | Nebulizer | JONAITIS, JUSTIN M | — |
| Art Unit | Apps |
|---|---|
| 2924 | 1 |
| 3785 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18832326 | INHALATION THERAPY APPARATUS | JANG, JAEICK | — | §112 | Non-Final OA | — | Pending | Jul 23, 2024 |
| 35519927 | Nebulizer | JONAITIS, JUSTIN M | 2924 | §112 | Non-Final OA | — | Pending | Nov 23, 2023 |
| 17785493 | CONTROL DEVICE FOR AEROSOL NEBULIZER SYSTEM | GREIG, THOMAS W | 3785 | §103 | Non-Final OA | 14d | Pending | Jun 15, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial